查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2056333

分子診斷市場報告：按產品、技術、應用、最終用戶和地區分類（2026-2034 年）

Molecular Diagnostics Market Report by Product, Technology (Polymerase Chain Reactions, Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology, and Others), Application, End Users, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2025年全球分子診斷市場規模達221億美元。展望未來，IMARC Group預測，2026年至2034年該市場將以5.52%的複合年成長率成長，到2034年達到363億美元。感染疾病和遺傳疾病的日益普及、聚合酵素鏈鎖反應（PCR）技術的進步、人口老化、人們對疾病早期檢測意識的提高以及政府的支持措施正在塑造市場趨勢。

分子診斷市場的發展趨勢：

慢性疾病和感染疾病的盛行率增加

該市場正呈現顯著成長，主要驅動力是急慢性疾病病例的不斷增加。癌症、心臟病和感染疾病等疾病發病率的上升凸顯了分子診斷在快速準確診斷這些疾病方面發揮的關鍵作用。這項特性不僅能改善患者預後，還能發展出針對個別反應的個人化治療方案，進而進一步提升市場對分子診斷的需求。隨著全球健康狀況日益複雜，對尖端分子診斷設備的需求也不斷成長，進一步推動了市場發展。根據衛生署報告顯示，2016年，非傳染性疾病（NCDs）導致的死亡人數佔所有死亡人數的61%，致殘人數佔所有殘障人士的55%。

基因組學和個人化醫療領域的技術進步

基因組學和個人化醫療領域正取得顯著進展，這對全球分子診斷市場至關重要。新一代DNA定序技術（如DNA定序、基因表現和RNA定序）在基因譜分析方面的創新至關重要，它們革新了診斷方法，並能夠識別特定的疾病標記和遺傳易感性。個人化醫療根據個體的基因譜最佳化治療方案，這催生了對能夠準確解讀複雜基因資訊的先進診斷技術的需求。隨著先進技術與個人化醫療的整合不斷加深，市場佔有率也不斷擴大。

根據一份關於個人化醫療的報告，美國總統歐巴馬於 2015 年推出了精準醫療舉措(PMI)。該舉措為研究人員提供安全存取大量基因組數據的途徑，最初為數千個數據，未來可能擴展到一百萬個數據，以便進行詳細研究。

人口老化和對標靶診斷的需求

老年族群中神經退化性疾病疾病和心血管疾病的日益普遍，推動了對高效診斷方法的需求成長。分子診斷具有早期發現疾病的寶貴功能，從而為便捷治療提供清晰的途徑，並改善治療效果。這種人口結構的變化導致對非侵入性、精準的檢測工具（例如晶片實驗室（LOA）技術）的需求顯著增加，表明市場細分正在朝著適應這些新興健康需求的方向發展。這種人口結構的變化是分子診斷市場分析的關鍵因素。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球分子診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 試劑和試劑盒
  • 裝置
  • 軟體和服務

第7章 市場區隔：依技術分類

  • 聚合酵素鏈鎖反應（PCR）
  • 雜合反應
  • DNA定序
  • 微陣列
  • 恒溫核酸增幅技術（INAAT）
  • 其他

第8章 市場區隔：依應用領域分類

  • 感染疾病診斷
  • 腫瘤學
  • 基因檢測
  • 血液篩檢
  • 其他

第9章 市場區隔：依最終用戶分類

  • 醫院
  • 研究所
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章：價格分析

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Becton Dickinson and Company
    • Biomerieux SA
    • Danaher Corporation
    • Diasorin Molecular LLC（DiaSorin SpA）
    • F. Hoffmann-La Roche AG（Roche Holding AG）
    • Hologic Inc.
    • Illumina Inc.
    • Myriad Genetics Inc.
    • Qiagen
    • Quidel Corporation
    • Thermo Fisher Scientific
Product Code: SR112026A5726

The global molecular diagnostics market size reached USD 22.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 36.3 Billion by 2034, exhibiting a growth rate (CAGR) of 5.52% during 2026-2034. The increasing prevalence of infectious diseases and genetic disorders, technological advancements in polymerase chain reaction (PCR), growing aging population, surging awareness of early disease detection, and supportive government initiatives are factors shaping the market's trajectory.

Molecular Diagnostics Market Analysis:

Major Market Drivers: The market for molecular diagnostics is expanding primarily due to rise in chronic and infectious illnesses which in turn is leading to growing demand for accurate diagnostics methods. In addition, the continual advancements in genomic and personalized medicine are contributing to the molecular diagnostics market growth.

Key Market Trends: Substantial trends include the demand for PCR as it is accurate and fast and the increase in reagents and kits due to the new methodologies and diagnostic technologies. Besides, the movement towards non-invasive, early diagnosis approaches is also supporting the demand.

Geographical Trends: North America is the leader in the world, due to the presence of advanced medical infrastructure, more investments in R&D and a great emphasis on personalized medicine. In addition, Asia-Pacific faces a fast development through increasing resource usage and more health-related knowledge and spendings.

Competitive Landscape: The key competitive companies that are constantly contributing to the market are Roche Diagnostics, Abbott Laboratories, QIAGEN, Bio-Rad Laboratories, Siemens Healthineers, and Thermo Fisher Scientific and others. These enterprises invest heavily in the new technologies and partnerships to maintain the molecular diagnostics market share and occupy new territories.

Challenges and Opportunities: The barriers are regulatory intricacies and finances of the molecular diagnostics. Along with the challenges, new opportunities emerge for healthcare providers from the growing healthcare needs in the emerging markets and from the constant technological advances which promise better diagnostics and expand the market.

Molecular Diagnostics Market Trends:

Increasing prevalence of chronic and infectious diseases

The market is exhibiting an outstanding growth rate which is mainly due to the increasing cases of acute and chronic illnesses. This increase in disease occurrence, including cancer, heart diseases, and infection focuses on the significant role of the molecular diagnostics in giving fast and proper diagnosis of the disease. This attribute enables the better patient outcomes and also constitutes individual response personalized treatment plans, which increases the molecular diagnostics demand in the market. Along with the expanding complexities of health conditions all over the world, the demand for newfangled molecular diagnostic equipment is rising, which in turn perpetuates the market growth. According to a report by the ministry of health, in 2016, non-communicable diseases (NCDs) accounted for 61% of all mortalities and 55% of disability cases.

Technological advancements in genomics and personalized medicine

The sector is experiencing developments in genomics and personalized medicine that are crucial for the global molecular diagnostics market trends. Genetic profiling innovations for DNA sequencing, gene expression, and next-generation DNA sequencing such as RNA are essential and changing the ways of diagnosis and allowing the identification of specific disease markers and genetic predispositions. The utilization of personalized medicine, which entails to tailoring treatment based on the individual's genetic profile, is creating a need for sophisticated diagnostic technologies, that is able to decipher complex genetic information accurately. The rising cooperation between sophisticated technologies and tailored treatments is expanding the market share.

According to the personalized medicine report, in 2015, U.S. President Barack Obama launched the precision medicine initiative (PMI). This initiative offers researchers secure access to an extensive array of genomic data, starting with thousands and potentially expanding to one million genome sequences, for in-depth scientific research.

Rising aging population and demand for targeted diagnostics

The demand for efficient diagnostic method is rising due to rising illnesses, such as neurodegenerative disorders and cardiovascular problems in geriatric populations. Molecular diagnostics offer a valuable functionality of early detection of health conditions, thus providing a clear path for treatment at convenient and improved outcomes. The growing trend of this demographic is significantly increasing demand for non-invasive and accurate tools such as lab-on-a-chip (LOA) technology which is indicative of an increasing market segment's inclination to adapt to this new health requirement. This population shift is a significant contributing to the molecular diagnostics market analysis.

Molecular Diagnostics Market Segmentation:

This report provides an analysis of the key trends in each segment of the global molecular diagnostics market report, along with forecasts at the global, regional, and country levels for 2026-2034. The report categorizes the market based on product, technology, application, and end users.

Breakup by Product:

  • Reagents and Kits
  • Instruments
  • Software and Services

Reagents and kits dominate the market

The market is experiencing a significant increase, particularly in the reagents and kits segment, due to the expansion of molecular diagnostics reach into various medical areas of specialization. Fresh paradigms in research and novel inventions generate novel assays and testing methods that require the appropriate reagents and kits to be feasible. The growing number of chronic diseases make the need for fast and dependable diagnostic tools more crucial, driving the increase. Involvement of the major companies with research institutions also has an impact on the development of new reagents and kits, and hence plays a significant part in increasing the molecular diagnostics market revenue.

Breakup by Technology:

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

Polymerase chain reactions (PCR) dominate the market

The PCR segment is dominating the molecular diagnostics market outlook. The advent of PCR technology refinements, including the designing and constructing of qPCR and dPCR, propel the amplification's biochemical process, thereby improves the sensitivity, accuracy, and speed. Such advancement of PCR has made it an indispensable instrument in molecular diagnostics. Precise analysis of genetic profiles which can be used in personalized medicine and targeted therapies is now essential to these treatments. Besides, the point-of-care diagnostics advancement and PCR platform introduction into both of the healthcare professionals and patients make molecular testing more available this leads broaden its integration among healthcare environments.

Breakup by Application:

  • Infectious Diseases Diagnostics
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Infectious diseases diagnostics dominate the market

The molecular diagnostics market overview explains that the market dynamics are in line with rapid spread of infectious diseases, encompassing viral, bacterial, and fungal infections. The rapid spread of diseases, especially those which have the potential to plunge the world into pandemics, has caused an urgent need for early detection mechanism and the use of viable containment strategies. The advent of molecular biology and immunoassay technologies in diagnostics revolutionized this landscape by enhancing the accuracy and speed of pathogen detection and typing for their resistances. This breakthrough has led to the creation of a promising market for molecular diagnostics and indicates a strong trend of the growth of preventive health and surveillance projects. These measures play an important role in the medical involvement and stopping the spread of infections.

Breakup by End Users:

  • Hospitals
  • Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest molecular diagnostics market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for molecular diagnostics.

North America market is growing due to the strong culture of perpetual research and development innovation, as per the molecular diagnostics market forecast period. With the increase in the development of chronic diseases, such as cancer, cardiovascular diseases and diabetes, the rapid and reliable detection methods are required. The increased level of personalized medicine understanding in healthcare professionals and patients alongside other factors is propelling the market growth. Development of government aid in the healthcare modernization and the establishment of molecular diagnostics techniques are the major economies drivers in the business growth. Furthermore, DTC genetic testing is also a significant part which improves the level of consumer interaction and supports the molecular diagnostics market recent opportunities.

Competitive Landscape:

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton Dickinson and Company
  • Biomerieux SA
  • Danaher Corporation
  • Diasorin Molecular LLC (DiaSorin)
  • F. Hoffmann-La Roche AG (Roche Holding AG)
  • Hologic Inc.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • Qiagen
  • Quidel Corporation
  • Thermo Fisher Scientific

Key Questions Answered in This Report

1. How big is the molecular diagnostics market?

2. What is the future outlook of molecular diagnostics market?

3. What are the key factors driving the molecular diagnostics market?

4. Which region accounts for the largest molecular diagnostics market share?

5. Which are the leading companies in the global molecular diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Polymerase Chain Reactions (PCR)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hybridization
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA Sequencing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Microarray
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Infectious Diseases Diagnostics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Genetic Testing
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Blood Screening
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Becton Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Biomerieux SA
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Danaher Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Diasorin Molecular LLC (DiaSorin S.p.A.)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 SWOT Analysis
    • 15.3.8 Hologic Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Qiagen
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quidel Corporation
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
    • 15.3.13 Thermo Fisher Scientific
      • 15.3.13.1 Company Overview
      • 15.3.13.2 Product Portfolio
      • 15.3.13.3 Financials
      • 15.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Molecular Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Molecular Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Molecular Diagnostics Market: Breakup by Product (in %), 2025
  • Figure 5: Global: Molecular Diagnostics Market: Breakup by Technology (in %), 2025
  • Figure 6: Global: Molecular Diagnostics Market: Breakup by Application (in %), 2025
  • Figure 7: Global: Molecular Diagnostics Market: Breakup by End Users (in %), 2025
  • Figure 8: Global: Molecular Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Molecular Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Molecular Diagnostics (Reagents and Kits) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Molecular Diagnostics (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Molecular Diagnostics (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Molecular Diagnostics (Software and Services) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Molecular Diagnostics (Software and Services) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Molecular Diagnostics (Polymerase Chain Reactions (PCR)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Molecular Diagnostics (Hybridization) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Molecular Diagnostics (Hybridization) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Molecular Diagnostics (DNA Sequencing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Molecular Diagnostics (DNA Sequencing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Molecular Diagnostics (Microarray) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Molecular Diagnostics (Microarray) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Molecular Diagnostics (Isothermal Nucleic Acid Amplification Technology (INAAT)) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Molecular Diagnostics (Other Technologies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Molecular Diagnostics (Other Technologies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Molecular Diagnostics (Infectious Diseases Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Molecular Diagnostics (Oncology) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Molecular Diagnostics (Oncology) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Molecular Diagnostics (Genetic Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Molecular Diagnostics (Genetic Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Molecular Diagnostics (Blood Screening) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Molecular Diagnostics (Blood Screening) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Molecular Diagnostics (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Molecular Diagnostics (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Molecular Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Molecular Diagnostics (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Molecular Diagnostics (Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Molecular Diagnostics (Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Molecular Diagnostics (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Molecular Diagnostics (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: North America: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: North America: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: United States: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: United States: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: Canada: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: Canada: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Asia-Pacific: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Asia-Pacific: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: China: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: China: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Japan: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Japan: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: India: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: India: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: South Korea: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: South Korea: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Australia: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Australia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Indonesia: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Indonesia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Europe: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Europe: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Germany: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Germany: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: France: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: France: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: United Kingdom: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: United Kingdom: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Italy: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Italy: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Spain: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Spain: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Russia: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Russia: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Latin America: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Latin America: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Brazil: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Brazil: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Mexico: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Mexico: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Others: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Others: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Middle East and Africa: Molecular Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Middle East and Africa: Molecular Diagnostics Market: Breakup by Country (in %), 2025
  • Figure 91: Middle East and Africa: Molecular Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 92: Global: Molecular Diagnostics Industry: SWOT Analysis
  • Figure 93: Global: Molecular Diagnostics Industry: Value Chain Analysis
  • Figure 94: Global: Molecular Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Molecular Diagnostics Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: Molecular Diagnostics Market Forecast: Breakup by Technology (in Million USD), 2026-2034
  • Table 4: Global: Molecular Diagnostics Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Molecular Diagnostics Market Forecast: Breakup by End Users (in Million USD), 2026-2034
  • Table 6: Global: Molecular Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Molecular Diagnostics Market: Competitive Structure
  • Table 8: Global: Molecular Diagnostics Market: Key Players